Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The answer from PTSC to the USPTO contingency is .....
Thank you, strandl. That relieves my mind. I wondered why they would do that as our patents are valid now and were valid at the time of the Markman. Just b/c another co. challanges them does not make them invalid. It seems as challanging patents has become a way to hurt some patent holders. GL, ads
Share
New Message
Please login to post a reply